Quantcast

Posts related to ‘Medical’

Revised Guidance Sinks Health Care Company (CNC, MOH, AGP, UNH, WCG)

To say that Centene Corp. (NYSE: CNC), a managed health care provider, has been on a roller coaster ride for the past few days may be an understatement. First, it ...
Read Full Story »

Merger Monday Heads to the Lab (MTOX, LH)

Merger and acquisition news has been a bit light of late, but there is at least one deal out there this Monday for M&A watchers to chew over.  MEDTOX Scientific, Inc. ...
Read Full Story »

Does DaVita Acquisition Make Warren Buffett Rethink His Kidney Dialysis Bet?

DaVita Inc. (NYSE: DVA) is facing a bit of a drag on its announcement that it is spending some $4.4 billion to acquire HealthCare Partners.  This is a transformative deal ...
Read Full Story »

An Early Look at 2012 ASCO Biotech Cancer Stocks (DNDN, LLY, AMGN, ARIA, ARQL, ARRY, AVEO, BVTI, ABPI, BMY, CLDX, CYTR, CYCC, GALE, EXEL, GNBT, GHDX, IMGN, MYGN, NKTR, NLNK, ONXX, OPTR, PCYC, SGEN, SNSS, SNTA)

We are now just about two weeks away from the king of biotech and pharma events in cancer treatments.  The 2012 annual meeting of the American Society of Clinical Oncology (ASCO) ...
Read Full Story »

IPO Filing From KYTHERA: Fighting The Double Chin

KYTHERA Biopharmaceuticals, Inc. has just joined in with the companies which have filed to come public via an initial public offering.  The common stock plans to be listed on The ...
Read Full Story »

Rosetta Genomics Share Offering: No Good Deeds Go Unpunished

Rosetta Genomics, Ltd. (NASDAQ: ROSG) was an exponential winner on Wednesday due to getting a Medicare reimbursement ruling in its favor.  The company had announced that the Medicare Administrative Contractor ...
Read Full Story »

Rosetta Genomics Joins Exponential Explosion Club on Medicare Coverage

Rosetta Genomics Ltd. (NASDAQ: ROSG) is not often in the news, but it is in the news a big way now.  The microRNA-based molecular diagnostic test maker has announced that Novitas, ...
Read Full Story »

Taking An Early Look at 2012 ASCO Biotech/Cancer Stocks (DNDN, LLY, ARIA, ARRY, BVTI, ABPI, CLDX, CYTR, GALE, EXEL, GNBT, GHDX, IMGN, NKTR, NLNK, PCYC, SGEN)

It is now getting close to the middle of May, and that means one thing for biotech investors.  The king of biotech and pharma events is about to take place.  ...
Read Full Story »

America Adjusts for Obesity

Authors of a new CDC study, widely covered in the press, reported that the number of Americans considered obese will rise to 42% of the population by 2030. The medical costs of ...
Read Full Story »

Another Medical Company Goes To Europe… Kensey Nash Buyout At All-Time High (KNSY)

Kensey Nash Corporation (NASDAQ: KNSY) is well-known for its regenerative tissue materials, but it is soon going to be known under a new name or at least with a new owner ...
Read Full Story »

J&J Joins Dividend Hike One-Up Game (JNJ, PFE, MRK)

How many DJIA components can raise their dividend in one week?  Johnson & Johnson (NYSE: JNJ) answered that question as "Who knows, but we can make it one more!"  J&J ...
Read Full Story »

Social Security, Medicare Still Going Broke

The annual report of the Trustees of the Social Security and Medicare trust funds has been released, and no matter what one believes about how the US should provide a ...
Read Full Story »

VIVUS Faces Shareholder Risks After FDA Delay On Obesity Pill (VVUS, ARNA, OREX)

VIVUS Inc. (NASDAQ: VVUS) is getting a bit of a haircut this morning on the heels of some news from the Food & Drug Administration which may throw up some ...
Read Full Story »

Ohio Medicaid Losses Wreck Providers (MOH, CNC, AGP, WCG)

Molina Healthcare Inc. (NYSE: MOH) and Centene Corporation (NYSE: CNC) are both seeing their shares take a real beating.  On a day where most stocks are lower because of Friday's ...
Read Full Story »

Health Care Spending Flattens as U.S. Results Stagger

A new study from research firm IMS shows that new and better treatments for disease and a dip in physician visits steadied health care spending in the United States last year. It should be considered good ...
Read Full Story »